Carcinoma, Hepatocellular: all 3,251 studies

Page 12 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.

• Contrast-enhanced Ultrasound Evaluation of ChemoembolizationCompletedNCT02764801Phase 3Results posted
• Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial ChemoembolizationTerminatedNCT02762266Phase 3Results posted
• Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid TumorsCompletedNCT02705105Phase 1/2Results posted
• TAE and MWA Combination Therapy in Early-stage Hepatocellular CarcinomaTerminatedNCT02704130Not applicableResults posted
• Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)CompletedNCT02702414Phase 2Results posted
• Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240)CompletedNCT02702401Phase 3Results posted
• [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver CancerCompletedNCT02695628Phase 2Results posted
• Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCCCompletedNCT02670122Results posted
• Pembrolizumab (Keytruda) in Advanced Hepatocellular CarcinomaCompletedNCT02658019Phase 2Results posted
• LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic TumorsTerminatedNCT02649868Not applicableResults posted
• Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety StudyCompletedNCT02635347Not applicableResults posted
• An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular CarcinomaCompletedNCT02576509Phase 3Results posted
• MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular CarcinomaTerminatedNCT02575339Phase 1/2Results posted
• Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib AloneCompletedNCT02562755Phase 3Results posted
• Trial of TRC105 and Sorafenib in Patients With HCCCompletedNCT02560779Phase 1/2Results posted
• 11C-acetate for Treatment Response After Radiotherapy for HCCTerminatedNCT02549755Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT02528643Phase 2Results posted
• LEE001 and Chemoembolization In Patients With Advanced Hepatocellular CarcinomaTerminatedNCT02524119Phase 2Results posted
• A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular CarcinomaActive, not recruitingNCT02519348Phase 2Results posted
• Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular CarcinomaCompletedNCT02513199Phase 2Results posted
• Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver MetastasesCompletedNCT02511522Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular CarcinomaTerminatedNCT02504099Phase 3Results posted
• A Study of ONCO-DOX in Locally Advanced Hepatocellular CarcinomaTerminatedNCT02460991Phase 3Results posted
• A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular CarcinomaCompletedNCT02460835Not applicableResults posted
• A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-FetoproteinCompletedNCT02435433Phase 3Results posted
• Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response EvaluationCompletedNCT02424955Not applicableResults posted
• A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular CarcinomaCompletedNCT02423343Phase 1/2Results posted
• Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsCompletedNCT02344680Results posted
• KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic CancerCompletedNCT02337465Not applicableResults posted
• Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)CompletedNCT02329860Phase 3Results posted
• FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB ExpressionCompletedNCT02325739Phase 1/2Results posted
• Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular CarcinomaTerminatedNCT02314052Phase 1/2Results posted
• Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive CancerActive, not recruitingNCT02293954Not applicableResults posted
• A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular CarcinomaCompletedNCT02279719Phase 1/2Results posted
• Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the LiverCompletedNCT02273362Phase 1/2Results posted
• A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar CarcinomaCompletedNCT02234986Phase 2Results posted
• Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver TransplantCompletedNCT02182687Phase 2Results posted
• A Study of LY2157299 in Participants With Advanced Hepatocellular CarcinomaCompletedNCT02178358Phase 2Results posted
• Molecular-Guided Therapy for Childhood CancerCompletedNCT02162732Not applicableResults posted
• TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic ReserveTerminatedNCT02147301Not applicableResults posted
• Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)CompletedNCT02128958Phase 2Results posted
• c-Met Second-Line Hepatocellular CarcinomaCompletedNCT02115373Phase 1/2Results posted
• Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)CompletedNCT02112656Phase 3Results posted
• Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver LesionsCompletedNCT02095678Not applicableResults posted
• A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced CancerCompletedNCT02082210Phase 1/2Results posted
• A2ALL-Patients Safety System Improvements in Living Donor Liver TransplantationCompletedNCT02073435Results posted
• A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver CancerCompletedNCT02069041Phase 1Results posted
• 3-Tesla MRI Response to TACE in HCC (Liver Cancer)TerminatedNCT02057874Not applicableResults posted
• Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by SurgeryCompletedNCT02042443Phase 2Results posted
• Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT02024087Phase 1/2Results posted
• Phase 1-2 Trial HCQ Plus TACE in Unresectable HCCTerminatedNCT02013778Phase 1/2Results posted
• Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular CarcinomaCompletedNCT02007954Phase 2Results posted
• Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular CarcinomaCompletedNCT01988493Phase 1/2Results posted
• T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing CancerCompletedNCT01967823Phase 2Results posted
• Effect of Colchicine for the Palliative Management of Hepatocellular CarcinomaCompletedNCT01935700Phase 2Results posted
• A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver CancerTerminatedNCT01911273Phase 2Results posted
• Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior SorafenibCompletedNCT01908426Phase 3Results posted
• Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT01900002Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT01899261Not applicableResults posted
• Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal VeinTerminatedNCT01887717Phase 3Results posted
• Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)CompletedNCT01871545Not applicableResults posted
• Tremelimumab With Chemoembolization or Ablation for Liver CancerCompletedNCT01853618Phase 1/2Results posted
• HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)TerminatedNCT01849588Phase 4Results posted
• A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular CarcinomaCompletedNCT01839604Phase 1Results posted
• Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01835223Phase 1/2Results posted
• Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)TerminatedNCT01821963Phase 3Results posted
• Phase II Trial of Tivozanib in Advanced Hepatocellular CancerTerminatedNCT01807156Phase 2Results posted
• DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCCTerminatedNCT01806740Phase 4Results posted
• Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular CarcinomaCompletedNCT01798134Not applicableResults posted
• Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid TestsCompletedNCT01790633Not applicableResults posted
• Sorafenib + mFOLFOX for Hepatocellular CarcinomaCompletedNCT01775501Phase 2Results posted
• Study of Regorafenib After Sorafenib in Patients With Hepatocellular CarcinomaCompletedNCT01774344Phase 3Results posted
• Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical HepatectomyCompletedNCT01770431Phase 4Results posted
• Application of HBV Rapid Tests as a Tool for Wide-Use ScreeningCompletedNCT01767597Not applicableResults posted
• A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular CarcinomaCompletedNCT01761266Phase 3Results posted
• Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior TherapyCompletedNCT01755767Phase 3Results posted
• A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and EffectiveCompletedNCT01754987Phase 1/2Results posted
• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)CompletedNCT01752933Phase 2Results posted
• A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric CancersCompletedNCT01743469Phase 2Results posted
• Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma.TerminatedNCT01737827Phase 2Results posted
• Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver CancerCompletedNCT01730937Phase 3Results posted
• Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01687673Phase 2Results posted
• A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as MonotherapyTerminatedNCT01668017Phase 1Results posted
• Advanced Image Guidance Utilized in Liver SurgeryCompletedNCT01666145Not applicableResults posted
• An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver CancerCompletedNCT01658878Phase 1/2Results posted
• Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular CarcinomaCompletedNCT01655693Phase 3Results posted
• Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)CompletedNCT01642186Phase 2Results posted
• Hepatic Xenetix-CT PerfusionCompletedNCT01639703Phase 4Results posted
• Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01639352Phase 2Results posted
• Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular CarcinomaCompletedNCT01594125Phase 1Results posted
• Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-TransplantCompletedNCT01559844Phase 2Results posted
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver CancerCompletedNCT01556490Not applicableResults posted
• Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle AspirationCompletedNCT01549275Results posted
• A Study of Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degrees of Renal or Hepatic FunctionCompletedNCT01546519Phase 1Results posted
• A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic CancerCompletedNCT01522937Phase 2Results posted
• Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)TerminatedNCT01521780Phase 1Results posted
• Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid CancerCompletedNCT01502410Phase 2Results posted
• MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.CompletedNCT01498952Phase 1Results posted
• Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNCT01488487Phase 2Results posted
• Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular CarcinomaTerminatedNCT01465464Phase 3Results posted

← Carcinoma, Hepatocellular overview